Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Bennett CL, et al. Among authors: casadevall n. Blood. 2005 Nov 15;106(10):3343-7. doi: 10.1182/blood-2005-02-0508. Epub 2005 Aug 11. Blood. 2005. PMID: 16099877 Free PMC article.
Biosimilars need comparative clinical data.
Casadevall N, Thorpe R, Schellekens H. Casadevall N, et al. Kidney Int. 2011 Sep;80(5):553. doi: 10.1038/ki.2011.164. Kidney Int. 2011. PMID: 21841836 No abstract available.
Importance of biologic follow-ons: experience with EPO.
Casadevall N, Rossert J. Casadevall N, et al. Best Pract Res Clin Haematol. 2005;18(3):381-7. doi: 10.1016/j.beha.2005.01.014. Best Pract Res Clin Haematol. 2005. PMID: 15792912 Review.
208 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page